KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Halozyme Therapeutics (HALO) Intangibles (2022 - 2025)

Historic Intangibles for Halozyme Therapeutics (HALO) over the last 4 years, with Q3 2025 value amounting to $348.5 million.

  • Halozyme Therapeutics' Intangibles fell 1693.26% to $348.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $348.5 million, marking a year-over-year decrease of 1693.26%. This contributed to the annual value of $401.8 million for FY2024, which is 1502.48% down from last year.
  • According to the latest figures from Q3 2025, Halozyme Therapeutics' Intangibles is $348.5 million, which was down 1693.26% from $366.3 million recorded in Q2 2025.
  • Over the past 5 years, Halozyme Therapeutics' Intangibles peaked at $976.1 million during Q2 2022, and registered a low of $348.5 million during Q3 2025.
  • Over the past 4 years, Halozyme Therapeutics' median Intangibles value was $464.0 million (recorded in 2023), while the average stood at $520.6 million.
  • The largest annual percentage gain for Halozyme Therapeutics' Intangibles in the last 5 years was 1349.54% (2023), contrasted with its biggest fall of 4829.39% (2023).
  • Over the past 4 years, Halozyme Therapeutics' Intangibles (Quarter) stood at $546.7 million in 2022, then decreased by 13.5% to $472.9 million in 2023, then dropped by 15.02% to $401.8 million in 2024, then dropped by 13.26% to $348.5 million in 2025.
  • Its Intangibles was $348.5 million in Q3 2025, compared to $366.3 million in Q2 2025 and $384.1 million in Q1 2025.